Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma

Vittoria Rufini, Maria Lucia Calcagni, Salvatore Maria Corsello, Giorgio Treglia, Paola Castaldi, Germano Perotti, Aldo Giordano, G Galli, Silvia Fanti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

42 Citazioni (Scopus)

Abstract

Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.
Lingua originaleEnglish
pagine (da-a)575-582
Numero di pagine8
RivistaNuclear Medicine Communications
Volume32
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • 3-Iodobenzylguanidine
  • Adrenal Gland Neoplasms
  • Adult
  • Aged
  • Dihydroxyphenylalanine
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Paraganglioma
  • Paraganglioma, Extra-Adrenal
  • Pheochromocytoma
  • Positron-Emission Tomography
  • Recurrence
  • Retrospective Studies
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma'. Insieme formano una fingerprint unica.

Cita questo